|
KMID : 0869620120290020198
|
|
Journal of Korean Society of Hospital Pharmacists
2012 Volume.29 No. 2 p.198 ~ p.207
|
|
|
Enoxaparin versus Unfractionated Heparin for Thromboprophylaxis in Critically Ill patients
|
|
Choi Yu-Ri
Yoo Jae-Young
Park Hyo-Jung
In Yong-Won
Lee Young-Mee
|
|
|
Abstract
|
|
|
Venous thromboembolism (VTE) significantly contributes to the morbidity and mortality
associated with critical illnesses. Because the majority of patients admitted to a critical care
unit have multiple risk factors, American College of Chest Physicians recommends using a lowmolecular- weight heparin (LMWH) or unfractionated heparin (UFH) thromboprophylaxis. The aim of this study was to compare the effect of enoxaparin, a LMWH, to that of UFH on thromboprophylaxis efficacy and safety in critically ill patients.
In this retrospective study, we identified patients who received either enoxaparin or UFH for
thromboprophylaxis in the medical intensive care unit, during the calendar-year, 2010. We compared the incidence of VTE, thrombocytopenia, bleeding, and death during the hospital stay in the two groups.
A total of 38 patients receiving enoxaparin, and 24 patients receiving UFH for romboprophylaxis
were identified. No VTE events were observed in patients receiving UFH, whereas, 2 VTE
events were found in patients receiving enoxaparin. There was no significant difference between the groups in the rate of thrombocytopenia, and bleeding. ICU mortality and hospital mortality were similar between the two groups.
Among critically ill patients, enoxaparin was not superior to UFH in decreasing the incidence of
VTE, thrombocytopenia, bleeding, and mortality.
|
|
|
KEYWORD
|
|
|
Venous thromboembolism, thromboprophylaxis, enoxaparin, unfractionated heparin, critically ill patients
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|